???????? - IISS
????????????1949?????????1977?????????????. ?????70??????????????????????????????????.
?????????????: ?????????????????????????????????????. ??????????2??????(Mike Evans)??:???. ????????????????3? ?? ... ??????????????? - ?????????????????????????????????(?32/20? ... ??????????????????????????????????????. ??????????????????????????????????*. ???????????????????????????????????. ?????????????? ... ?????????? - ????????????????????????????????????????????. ????????????????????????????,?????????????. ????? ... Advancing breast cancer care in Europe: a roadmap to a women ...Breast cancer screening coverage rate in Europe (2011 to 2021)49. European guidelines recommend a minimum of 70-75% participation rate in ... Guidance for the Clinical Use of the Breast Cancer Polygenic Risk ...Our work aims to provide guidance on how PRSs can help identify women at higher risk of breast cancer and tailor their prevention and screening. Metastatic Breast Cancer - EMJESMO clinical practice guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer. Ann Oncol. 2021;32:1475-95. 1 ESMO Clinical Practice Guideline for the diagnosis, staging and ...This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing metastatic breast cancer. ? It covers diagnosis, staging, risk ... ESMO Asia 2025 Abstract RegulationsAbstract submission is free of charge and must be completed online only via the ESMO website. Abstracts submitted by e-mail, post or fax will not be accepted. Breast Cancer in Young Guidelines - Thieme ConnectThe ISMPO-BCY recommendations were adapted from current guidelines from the National Comprehensive Cancer Network and ESMO-BCY guidelines.9 ... AGO_2025E_16_Breast Cancer Follow-up_MASTER_schwarzEarly breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and ... 2025 ... Clinical course of 771 patients with bilateral breast cancer ... Hormone Receptor-positive, HER2-negative(2024) Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol , 35:159?182. Trastuzumab in combination with ...
